Clinical Trial Update: Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating rituximab with involved field radiotherapy in early-stage follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Lymphoma Malignant

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Klaus Herfarth, MD | Conditions: Lymphoma, Malignant | Phase 2 | Status: COMPLETED